Top Wall Street Forecasters Revamp HCA Healthcare Expectations Ahead Of Q2 Earnings

Benzinga

07/25

HCA Healthcare, Inc. (NYSE:HCA) will release earnings results for the second quarter before the opening bell on Friday, July 25.

Analysts expect the Nashville, Tennessee-based company to report quarterly earnings at $6.32 per share, up from $5.5 per share in the year-ago period. HCA Healthcare is projected to report quarterly revenue of $18.5 billion, compared to $17.49 billion a year earlier, according to data from Benzinga Pro.

On July 11, HCA Healthcare named John W. Chidsey, III as a new Independent Director.

HCA Healthcare shares dipped 3.3% to close at $341.48 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Truist Securities analyst Ryan Macdonald maintained a Buy rating and raised the price target from $390 to $415 on July 16, 2025. This analyst has an accuracy rate of 61%.
B of A Securities analyst Kevin Fishbeck downgraded the stock from Buy to Neutral and boosted the price target from $394 to $410 on July 16, 2025. This analyst has an accuracy rate of 67%.
JP Morgan analyst Benjamin Rossi assumed a Neutral rating with a price target of $380 on Dec. 17, 2024. This analyst has an accuracy rate of 67%.
Keybanc analyst Matthew Gillmor initiated coverage on the stock with an Overweight rating and a price target of $475 on Oct. 11, 2024. This analyst has an accuracy rate of 61%.

Considering buying HCA stock? Here’s what analysts think:

Read This Next:

Top 2 Tech Stocks You May Want To Dump This Quarter

Photo via Shutterstock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2554752154"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2554752154\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2554752154?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-25 16:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554752154","market":"hk","top_or_hot":-1,"title":"Top Wall Street Forecasters Revamp HCA Healthcare Expectations Ahead Of Q2 Earnings","media":"Benzinga","content":"<html><body><p><strong>HCA <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a>, Inc.</strong> (<a href=\"https://laohu8.com/S/NYSE\">NYSE</a>:HCA) will release earnings results for the second quarter before the opening bell on Friday, July 25.</p>\n<p>Analysts expect the Nashville, Tennessee-based company to report quarterly earnings at $6.32 per share, up from $5.5 per share in the year-ago period. HCA Healthcare is projected to report quarterly revenue of $18.5 billion, compared to $17.49 billion a year earlier, according to data from Benzinga Pro.</p>\n<p>On July 11, HCA Healthcare named John W. Chidsey, III as a new Independent Director.</p>\n<p>HCA Healthcare shares dipped 3.3% to close at $341.48 on Thursday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Truist Securities analyst Ryan Macdonald maintained a Buy rating and raised the price target from $390 to $415 on July 16, 2025. This analyst has an accuracy rate of 61%.</li>\n<li>B of A Securities analyst Kevin Fishbeck downgraded the stock from Buy to Neutral and boosted the price target from $394 to $410 on July 16, 2025. This analyst has an accuracy rate of 67%.</li>\n<li>JP Morgan analyst Benjamin Rossi assumed a Neutral rating with a price target of $380 on Dec. 17, 2024. This analyst has an accuracy rate of 67%.</li>\n<li>Keybanc analyst Matthew Gillmor initiated coverage on the stock with an Overweight rating and a price target of $475 on Oct. 11, 2024. This analyst has an accuracy rate of 61%.</li>\n</ul>\n<p>Considering buying HCA stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"570\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385-1024x570.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385-1024x570.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385.png 1117w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Top 2 Tech Stocks You May Want To Dump This Quarter</strong></li>\n</ul>\n<p>Photo via <a href=\"https://laohu8.com/S/SSTK\">Shutterstock</a></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Wall Street Forecasters Revamp HCA Healthcare Expectations Ahead Of Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Wall Street Forecasters Revamp HCA Healthcare Expectations Ahead Of Q2 Earnings\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2025-07-25 16:14</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong>HCA <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a>, Inc.</strong> (<a href=\"https://laohu8.com/S/NYSE\">NYSE</a>:HCA) will release earnings results for the second quarter before the opening bell on Friday, July 25.</p>\n<p>Analysts expect the Nashville, Tennessee-based company to report quarterly earnings at $6.32 per share, up from $5.5 per share in the year-ago period. HCA Healthcare is projected to report quarterly revenue of $18.5 billion, compared to $17.49 billion a year earlier, according to data from Benzinga Pro.</p>\n<p>On July 11, HCA Healthcare named John W. Chidsey, III as a new Independent Director.</p>\n<p>HCA Healthcare shares dipped 3.3% to close at $341.48 on Thursday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Truist Securities analyst Ryan Macdonald maintained a Buy rating and raised the price target from $390 to $415 on July 16, 2025. This analyst has an accuracy rate of 61%.</li>\n<li>B of A Securities analyst Kevin Fishbeck downgraded the stock from Buy to Neutral and boosted the price target from $394 to $410 on July 16, 2025. This analyst has an accuracy rate of 67%.</li>\n<li>JP Morgan analyst Benjamin Rossi assumed a Neutral rating with a price target of $380 on Dec. 17, 2024. This analyst has an accuracy rate of 67%.</li>\n<li>Keybanc analyst Matthew Gillmor initiated coverage on the stock with an Overweight rating and a price target of $475 on Oct. 11, 2024. This analyst has an accuracy rate of 61%.</li>\n</ul>\n<p>Considering buying HCA stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"570\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385-1024x570.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385-1024x570.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25041417/image-385.png 1117w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Top 2 Tech Stocks You May Want To Dump This Quarter</strong></li>\n</ul>\n<p>Photo via <a href=\"https://laohu8.com/S/SSTK\">Shutterstock</a></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCA","symbol_name":"HCA控股","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46624633/top-wall-street-forecasters-revamp-hca-healthcare-expectations-ahead-of-q2-earnings","article_id":"2554752154","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554752154","pubTimestamp":1753431294,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"HCA":"HCA控股"},"translate_title":"华尔街顶级预测者在第二季度收益公布前修改了HCA Healthcare的预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCA":1},"content_text":"HCA Healthcare, Inc. (NYSE:HCA) will release earnings results for the second quarter before the opening bell on Friday, July 25.\nAnalysts expect the Nashville, Tennessee-based company to report quarterly earnings at $6.32 per share, up from $5.5 per share in the year-ago period. HCA Healthcare is projected to report quarterly revenue of $18.5 billion, compared to $17.49 billion a year earlier, according to data from Benzinga Pro.\nOn July 11, HCA Healthcare named John W. Chidsey, III as a new Independent Director.\nHCA Healthcare shares dipped 3.3% to close at $341.48 on Thursday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nTruist Securities analyst Ryan Macdonald maintained a Buy rating and raised the price target from $390 to $415 on July 16, 2025. This analyst has an accuracy rate of 61%.\nB of A Securities analyst Kevin Fishbeck downgraded the stock from Buy to Neutral and boosted the price target from $394 to $410 on July 16, 2025. This analyst has an accuracy rate of 67%.\nJP Morgan analyst Benjamin Rossi assumed a Neutral rating with a price target of $380 on Dec. 17, 2024. This analyst has an accuracy rate of 67%.\nKeybanc analyst Matthew Gillmor initiated coverage on the stock with an Overweight rating and a price target of $475 on Oct. 11, 2024. This analyst has an accuracy rate of 61%.\n\nConsidering buying HCA stock? Here’s what analysts think: \n\nRead This Next: \n\nTop 2 Tech Stocks You May Want To Dump This Quarter\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}